← Leaderboards
Ronald G Blasberg
Sloan-Kettering Institute For Cancer Res
$11,404,709
Attributed
$18,038,953
Total exposure
20
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2005–22$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$35,844,715 · 21
By mechanism
P50$19,594,877 · 10
R01$13,955,830 · 7
R21$1,163,184 · 3
P01$1,130,824 · 1
Top collaborators
- Vladimir Ponomarev11 shared
- Jason A Koutcher10 shared
- Taha Merghoub7 shared
- Steven M Larson5 shared
- Kathryn Beal2 shared
- John L Humm2 shared
- Kayvan R Keshari2 shared
Most similar at Sloan-Kettering Institute For Cancer Res
Same institution · by research overlap
- Jason A Koutcher$20,695,436
- Paul J Sabbatini$3,542,584
- Vladimir Ponomarev$13,434,344
- Douglas J Ballon$17,261,176
- Harry W Strauss$434,999
Others in their field
Top investigators on “Image”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$332,241,999
- Leonard Freedman · Leidos Biomedical Research, Inc.$321,574,964
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$217,904,052
- Ethan Schreier · Associated Universities, Inc.$206,468,864
Research focus
ImageT-LymphocyteAnimalsPositron-Emission TomographyMemorial Sloan-Kettering Cancer CenterMonitorTumorNeoplastic CellClinical ResearchMagnetic Resonance ImagingResponseIn VivoReporterBaseMalignant NeoplasmsBiomedical FacilityInhibitor/AntagonistMalignant Neoplasm Of ProstateImmunotherapyTranslatingSuccessCellsIn Vivo Cellular And Molecular Imaging CentersAnimal Model
Grant awards (87)
Image-guided Trp-IDO/TDO-Kyn-AHR pathway inhibition, combined with immunotherapy$296,533
R01 · FY2022 · CA
Image-guided Trp-IDO/TDO-Kyn-AHR pathway inhibition, combined with immunotherapy$633,662
R01 · FY2021 · CA
Imaging tumor and T cell responses to metabolic and immune modulation therapy$718,818
R01 · FY2019 · CA · contact PI
Imaging Immune Modulation in Chimeric Antigen Receptor (CAR) T Cell Therapy$668,089
R01 · FY2019 · CA · contact PI
Enhancement of T cell therapy by incorporating adjunct treatment strategies$80,105
R01 · FY2019 · CA · contact PI
Imaging tumor and T cell responses to metabolic and immune modulation therapy$712,992
R01 · FY2018 · CA · contact PI
Imaging Immune Modulation in Chimeric Antigen Receptor (CAR) T Cell Therapy$657,305
R01 · FY2018 · CA · contact PI
Imaging tumor and T cell responses to metabolic and immune modulation therapy$70,499
R01 · FY2018 · CA · contact PI
Enhancement of T cell therapy by incorporating adjunct treatment strategies$23,150
R01 · FY2018 · CA · contact PI
Imaging tumor and T cell responses to metabolic and immune modulation therapy$712,992
R01 · FY2017 · CA · contact PI
Imaging Immune Modulation in Chimeric Antigen Receptor (CAR) T Cell Therapy$669,635
R01 · FY2017 · CA · contact PI
Imaging and Targeting Metastatic-Prone Breast Cancer$560,220
R01 · FY2017 · CA · contact PI
Imaging tumor and T cell responses to metabolic and immune modulation therapy$59,901
R01 · FY2017 · CA · contact PI
Imaging Immune Modulation in Chimeric Antigen Receptor (CAR) T Cell Therapy$645,363
R01 · FY2016 · CA · contact PI
Imaging and Targeting Metastatic-Prone Breast Cancer$559,473
R01 · FY2016 · CA · contact PI
Tumor microenvironment: Impact on T cell tumor-targeting, activation and survival$470,514
R01 · FY2016 · CA · contact PI
MSKCC Center for Molecular Imaging in Cancer$1,471,710
P50 · FY2015 · CA
Imaging and Targeting Metastatic-Prone Breast Cancer$562,279
R01 · FY2015 · CA · contact PI
Tumor microenvironment: Impact on T cell tumor-targeting, activation and survival$505,733
R01 · FY2015 · CA · contact PI
Imaging T Cell Targeting and Function in Human Cancer$238,296
P50 · FY2015 · CA · contact PI
MSKCC Center for Molecular Imaging in Cancer$1,455,670
P50 · FY2014 · CA
Imaging and Targeting Metastatic-Prone Breast Cancer$549,750
R01 · FY2014 · CA · contact PI
Tumor microenvironment: Impact on T cell tumor-targeting, activation and survival$503,520
R01 · FY2014 · CA · contact PI
18F-Fluorocholine to distinguish necrosis from recurrence in brain metastases$355,854
R21 · FY2014 · CA
Imaging T Cell Targeting and Function in Human Cancer$223,320
P50 · FY2014 · CA · contact PI
MSKCC Center for Molecular Imaging in Cancer$1,524,418
P50 · FY2013 · CA
Imaging and Targeting Metastatic-Prone Breast Cancer$564,961
R01 · FY2013 · CA · contact PI
Tumor microenvironment: Impact on T cell tumor-targeting, activation and survival$490,230
R01 · FY2013 · CA · contact PI
18F-Fluorocholine to distinguish necrosis from recurrence in brain metastases$366,860
R21 · FY2013 · CA
Imaging T Cell Targeting and Function in Human Cancer$236,851
P50 · FY2013 · CA · contact PI
MSKCC Center for Molecular Imaging in Cancer$1,431,511
P50 · FY2012 · CA
Tumor microenvironment: Impact on T cell tumor-targeting, activation and survival$520,680
R01 · FY2012 · CA · contact PI
Imaging T Cell Targeting and Function in Human Cancer$216,969
P50 · FY2012 · CA · contact PI
MSKCC Center for Molecular Imaging in Cancer$1,580,501
P50 · FY2011 · CA
Imaging Core$258,026
P01 · FY2010 · CA · contact PI
Imaging T Cell Interactions in Adoptive Therapy of EBV-Associated Malignancies$223,946
P50 · FY2010 · CA · contact PI
Career Development Program$95,447
P50 · FY2010 · CA · contact PI
Organization and Administration$23,543
P50 · FY2010 · CA · contact PI
Imaging Core$254,280
P01 · FY2009 · CA · contact PI
Imaging T Cell Interactions in Adoptive Therapy of EBV-Associated Malignancies$223,946
P50 · FY2009 · CA · contact PI
Career Development Program$95,447
P50 · FY2009 · CA · contact PI
Organization and Administration$23,543
P50 · FY2009 · CA · contact PI
Imaging Signaling Changes in Cancer and Treatment$495,266
R01 · FY2008 · CA · contact PI
Imaging Core$248,203
P01 · FY2008 · CA · contact PI
Imaging T Cell Interactions in Adoptive Therapy of EBV-Associated Malignancies$122,643
P50 · FY2008 · CA · contact PI
Career Development Program$52,271
P50 · FY2008 · CA · contact PI
Organization and Administration$12,893
P50 · FY2008 · CA · contact PI
MSKCC Center for Molecular Imaging in Cancer$1,941,997
P50 · FY2007 · CA · contact PI
Imaging Signaling Changes in Cancer and Treatment$492,028
R01 · FY2007 · CA · contact PI
Imaging Core$247,381
P01 · FY2007 · CA · contact PI
MSKCC Center for Molecular Imaging in Cancer$1,999,955
P50 · FY2006 · CA · contact PI
Imaging Signaling Changes in Cancer and Treatment$455,258
R01 · FY2006 · CA · contact PI
Imaging Core$122,934
P01 · FY2006 · CA · contact PI
Imaging Signaling Changes in Cancer and Treatment$466,648
R01 · FY2005 · CA
Imaging Signaling Changes in Cancer and Treatment$388,813
R01 · FY2004 · CA
Imaging Brain Tumors with FACBC$210,625
R21 · FY2004 · CA
IMAGING TRANSGENE EXPRESSION IN GENE THERAPY PROTOCOLS$100,483
R01 · FY2004 · CA
Imaging Brain Tumors with FACBC$210,125
R21 · FY2003 · CA
MSKCC CENTER FOR IN VIVO MOLECULAR IMAGING IN CANCER$2,000,000
P50 · FY2002 · CA
MSKCC CENTER FOR IN VIVO MOLECULAR IMAGING IN CANCER$400,000
P50 · FY2002 · CA
IMAGING TRANSGENE EXPRESSION IN GENE THERAPY PROTOCOLS$320,930
R01 · FY2002 · CA
Core--Career development program$0
P50 · FY2002 · CA
Core--Development projects$0
P50 · FY2002 · CA
Core--Development projects$0
P50 · FY2002 · CA
Core--MSKCC facilities$0
P50 · FY2002 · CA
Core--MSKCC facilities$0
P50 · FY2002 · CA
Core--Molecular biology &vector development$0
P50 · FY2002 · CA
Core--Molecular biology &vector development$0
P50 · FY2002 · CA
Core--Quantitative autoradiographic &optical imaging$0
P50 · FY2002 · CA
Core--Quantitative autoradiographic &optical imaging$0
P50 · FY2002 · CA
Core--Career development program$0
P50 · FY2002 · CA
CORE--IMAGING FACILITY$0
P01 · FY2002 · CA
MSKCC CENTER FOR IN VIVO MOLECULAR IMAGING IN CANCER$2,000,000
P50 · FY2001 · CA
Core--Career development program$0
P50 · FY2001 · CA
Core--Development projects$0
P50 · FY2001 · CA
Core--MSKCC facilities$0
P50 · FY2001 · CA
Core--Molecular biology &vector development$0
P50 · FY2001 · CA
Core--Quantitative autoradiographic &optical imaging$0
P50 · FY2001 · CA
CORE--IMAGING FACILITY$0
P01 · FY2001 · CA
MSKCC CENTER FOR IN VIVO MOLECULAR IMAGING IN CANCER$2,000,000
P50 · FY2000 · CA
EARLY ASSESSMENT OF CYTOSTATIC DRUG RESPONSE$19,720
R21 · FY2000 · CA
Core--Career development program$0
P50 · FY2000 · CA
Core--Development projects$0
P50 · FY2000 · CA
Core--MSKCC facilities$0
P50 · FY2000 · CA
Core--Molecular biology &vector development$0
P50 · FY2000 · CA
Core--Quantitative autoradiographic &optical imaging$0
P50 · FY2000 · CA
CORE--IMAGING FACILITY$0
P01 · FY2000 · CA